OLIGONUCLEOTIDES FOR SARS-COV-2 MODULATION

This disclosure relates to novel SARS-CoV-2 targeting sequences. Novel SARS-CoV-2 targeting oligonucleotides for the treatment of SARS-CoV-2 infection are also provided.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TANG, Qi, KRISHNAMURTHY, Pranathi Meda, SOUSA, Jacquelyn, WATTS, Jonathon, LY, Socheata, KENNEDY, Zachary, O'REILLY, Daniel, GODINHO, Bruno, Miguel da Cruz, YAMADA, Ken, HILDEBRAND, Samuel, SHIN, Minwook, CAIAZZIA, Jillian, FERGUSON, Chantal, HARIHARAN, Vignesh Narayan, MCHUGH, Nicholas, MONOPOLI, Kathryn, KHVOROVA, Anastasia, THILLIER, Yann, ECHEVERRIA MORENO, Dimas, DEVI, Gitali, DAVIS, Sarah, BISCANS, Annabelle
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This disclosure relates to novel SARS-CoV-2 targeting sequences. Novel SARS-CoV-2 targeting oligonucleotides for the treatment of SARS-CoV-2 infection are also provided.